NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

viernes, 6 de febrero de 2026, 4:03 pm ET1 min de lectura
NAMS--

NewAmsterdam Pharma has announced the grant of inducement share options to four non-executive new hires, covering 217,000 ordinary shares. The options have an exercise price of $31.57 and will vest over four years, with 25% vesting after one year and the balance vesting in monthly installments. The shares are subject to the terms of the 2024 Inducement Plan and option award agreements.

NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios